In the overall Lewy body disorder cohort, GDF15 was positively correlated with age at onset of Parkinsonism, age at onset of dementia, H&Y stage, and with the neurodegenerative markers t-Tau and p-Tau. Here, MAPT is linked to Parkinson disease.